Form 4 for ONCO Onconetix, Inc.
Accepted 2024-09-26 00:00:00 ET · period of report 2024-09-24 · accession 0001213900-24-082238 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-26 | 2024-09-24 | ONCO | Schiess Ralph | CSO, Interim CEO | A - Grant | — | +489.2K | 495.9K | +7,254% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-24 | A | A | 489,160 | — | 495,903 | D | — | — | (F1) Represents shares of common stock of the Issuer issued to the Reporting Person upon automatic conversion of Series B preferred stock ("Preferred Shares") of the Issuer, in accordance with the Certificate of Designation for the Preferred Shares. |